Detalhe da pesquisa
1.
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry.
Ann Rheum Dis
; 80(9): 1137-1146, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34049860
2.
Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by van Vollenhoven et al.
Ann Rheum Dis
; 82(8): e178, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34389604
3.
Association Between Race/Ethnicity and COVID-19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID-19 Global Rheumatology Alliance.
Arthritis Care Res (Hoboken)
; 75(1): 53-60, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239292
4.
Development of a Prediction Model for COVID-19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry.
ACR Open Rheumatol
; 4(10): 872-882, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35869686
5.
COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance.
J Rheumatol
; 49(1): 110-114, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34470798
6.
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19.
JAMA Netw Open
; 4(10): e2129639, 2021 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34661663
7.
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study.
Lancet Rheumatol
; 3(12): e855-e864, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34778843